Results
|
481.
|
|
|
482.
|
|
|
483.
|
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. [electronic resource] by
- Tyner, Jeffrey W
- Walters, Denise K
- Willis, Stephanie G
- Luttropp, Mary
- Oost, Jason
- Loriaux, Marc
- Erickson, Heidi
- Corbin, Amie S
- O'Hare, Thomas
- Heinrich, Michael C
- Deininger, Michael W
- Druker, Brian J
Producer: 20080521
In:
Blood vol. 111
Availability: No items available.
|
|
484.
|
|
|
485.
|
|
|
486.
|
|
|
487.
|
|
|
488.
|
CD45 antigen negativity in T-lineage ALL correlates with PTPRC mutation and sensitivity to a selective JAK inhibitor. [electronic resource] by
- Raponi, Sara
- Gianfelici, Valentina
- Chiaretti, Sabina
- Peragine, Nadia
- Brugnoletti, Fulvia
- De Propris, Maria S
- Marinelli, Marilisa
- Hulselmans, Gert
- Aerts, Stein
- Geerdens, Ellen
- Cools, Jan
- Foà, Robin
- Guarini, Anna
Producer: 20160518
In:
British journal of haematology vol. 171
Availability: No items available.
|
|
489.
|
Baricitinib in Patients with Refractory Rheumatoid Arthritis. [electronic resource] by
- Genovese, Mark C
- Kremer, Joel
- Zamani, Omid
- Ludivico, Charles
- Krogulec, Marek
- Xie, Li
- Beattie, Scott D
- Koch, Alisa E
- Cardillo, Tracy E
- Rooney, Terence P
- Macias, William L
- de Bono, Stephanie
- Schlichting, Douglas E
- Smolen, Josef S
Producer: 20160409
In:
The New England journal of medicine vol. 374
Availability: No items available.
|
|
490.
|
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias. [electronic resource] by
- Kucine, Nicole
- Marubayashi, Sachie
- Bhagwat, Neha
- Papalexi, Efthymia
- Koppikar, Priya
- Sanchez Martin, Marta
- Dong, Lauren
- Tallman, Marty S
- Paietta, Elisabeth
- Wang, Kai
- He, Jie
- Lipson, Doron
- Stephens, Phil
- Miller, Vince
- Rowe, Jacob M
- Teruya-Feldstein, Julie
- Mullighan, Charles G
- Ferrando, Adolfo A
- Krivtsov, Andrei
- Armstrong, Scott
- Leung, Laura
- Ochiana, Stefan O
- Chiosis, Gabriela
- Levine, Ross L
- Kleppe, Maria
Producer: 20160318
In:
Blood vol. 126
Availability: No items available.
|
|
491.
|
|
|
492.
|
|
|
493.
|
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2. [electronic resource] by
- Zak, Mark
- Mendonca, Rohan
- Balazs, Mercedesz
- Barrett, Kathy
- Bergeron, Philippe
- Blair, Wade S
- Chang, Christine
- Deshmukh, Gauri
- Devoss, Jason
- Dragovich, Peter S
- Eigenbrot, Charles
- Ghilardi, Nico
- Gibbons, Paul
- Gradl, Stefan
- Hamman, Chris
- Hanan, Emily J
- Harstad, Eric
- Hewitt, Peter R
- Hurley, Christopher A
- Jin, Tian
- Johnson, Adam
- Johnson, Tony
- Kenny, Jane R
- Koehler, Michael F T
- Bir Kohli, Pawan
- Kulagowski, Janusz J
- Labadie, Sharada
- Liao, Jiangpeng
- Liimatta, Marya
- Lin, Zhonghua
- Lupardus, Patrick J
- Maxey, Robert J
- Murray, Jeremy M
- Pulk, Rebecca
- Rodriguez, Madeleine
- Savage, Scott
- Shia, Steven
- Steffek, Micah
- Ubhayakar, Savita
- Ultsch, Mark
- van Abbema, Anne
- Ward, Stuart I
- Xiao, Ling
- Xiao, Yisong
Producer: 20121001
In:
Journal of medicinal chemistry vol. 55
Availability: No items available.
|
|
494.
|
|
|
495.
|
|
|
496.
|
|
|
497.
|
|
|
498.
|
|
|
499.
|
|
|
500.
|
|